Name changed in June 2001 from BioNebraska Inc to Restoragen, Inc. which develops and produces peptide hormone therapies for age-related diseases. These peptide therapies have been shown that they may restore and regulate the body's natural endocrine hormone systems and have the potential to provide a better quality of life for people struggling with diseases associated with aging. These diseases may include type 2 diabetes, congestive heart failure, muscle frailty and osteoporosis
